CardioComm Press Release - February 07, 2007

CardioComm Solutions Inc. Announces Non-Brokered Financing

VICTORIA, B.C., February 7, 2007 – CardioComm Solutions Inc. (TSX-V:CCG) ("CardioComm", the “Company”), is pleased to announce a non- brokered private placement, for up to 10,000,000 units ("Units") of the Company at $0.06 per Unit, for total gross proceeds of up to (Cdn) $600,000 (the “Offering”).

Each Unit shall consist of one (1) common share ("Common Share") of the Company and one common share purchase warrant ("Warrant"). Every Warrant is exercisable into one additional Common Share at an exercise price of $0.10 per share on or before 24 months after the date of closing.

The Company intends to use the net proceeds from the Offering to initiate marketing efforts of its 12 -lead ECG product as well as for general working capital. A finder's fee issued in Units will be paid in connection with this transaction.

The proposed issuance of the securities is subject to regulatory approval, including the acceptance of the TSX Venture Exchange.

About CardioComm Solutions Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions Inc.

“Stephen Martin”

Stephen R. Martin, President & CEO

For investor information, please contact:

Stephen Martin
1-877-744-1122